Sonja Nowacki

475 total citations
8 papers, 385 citations indexed

About

Sonja Nowacki is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sonja Nowacki has authored 8 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Sonja Nowacki's work include Nicotinic Acetylcholine Receptors Study (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Sonja Nowacki is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Sonja Nowacki collaborates with scholars based in Germany, United States and Netherlands. Sonja Nowacki's co-authors include Andrea Wevers, Jon Lindstrom, Ernst N.H. Jansen Steur, Rob A. I. de Vos, Ulrich Schütz, Wilhelm Bloch, Hannsjörg Schröder, Lisa M. Monteggia, Alfred Maelicke and Heinz C. Schröder and has published in prestigious journals such as Oncogene, European Journal of Neuroscience and Behavioural Brain Research.

In The Last Decade

Sonja Nowacki

8 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonja Nowacki Germany 8 310 164 130 86 30 8 385
Ulrich Schütz Germany 10 436 1.4× 213 1.3× 204 1.6× 143 1.7× 44 1.5× 11 578
Noboru Iwakami Japan 9 174 0.6× 77 0.5× 118 0.9× 154 1.8× 18 0.6× 15 390
Paul M. Salvaterra United States 10 375 1.2× 87 0.5× 187 1.4× 133 1.5× 45 1.5× 10 577
Ana Sofía Vallés Argentina 12 317 1.0× 47 0.3× 150 1.2× 58 0.7× 10 0.3× 23 446
Malika Bennecib France 5 233 0.8× 54 0.3× 133 1.0× 199 2.3× 15 0.5× 6 442
Jeffrey N. Savas United States 7 215 0.7× 55 0.3× 157 1.2× 229 2.7× 25 0.8× 16 440
Tsunehiko Ono Japan 9 218 0.7× 42 0.3× 119 0.9× 213 2.5× 52 1.7× 11 397
Michael Pietropaolo United States 7 156 0.5× 79 0.5× 132 1.0× 256 3.0× 12 0.4× 13 418
Roberta Marolda Italy 8 140 0.5× 58 0.4× 169 1.3× 187 2.2× 73 2.4× 9 398
Sophie Crux Germany 8 129 0.4× 61 0.4× 105 0.8× 165 1.9× 15 0.5× 8 320

Countries citing papers authored by Sonja Nowacki

Since Specialization
Citations

This map shows the geographic impact of Sonja Nowacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Nowacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Nowacki more than expected).

Fields of papers citing papers by Sonja Nowacki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Nowacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Nowacki. The network helps show where Sonja Nowacki may publish in the future.

Co-authorship network of co-authors of Sonja Nowacki

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Nowacki. A scholar is included among the top collaborators of Sonja Nowacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Nowacki. Sonja Nowacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nowacki, Sonja, André Oberthuer, Harald Voth, et al.. (2007). Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma. Oncogene. 27(23). 3329–3338. 36 indexed citations
2.
Schröder, Hannsjörg, Ulrich Schütz, Lothar Burghaus, et al.. (2001). Expression of the α4 isoform of the nicotinic acetylcholine receptor in the fetal human cerebral cortex. Developmental Brain Research. 132(1). 33–45. 9 indexed citations
3.
Wevers, Andrea, Rob A. I. de Vos, Ernst N.H. Jansen Steur, et al.. (2001). Parvalbumin-containing interneurons of the human cerebral cortex express nicotinic acetylcholine receptor proteins. Journal of Chemical Neuroanatomy. 21(3). 239–246. 27 indexed citations
4.
Nyengaard, Jens Randel, Andrea Wevers, Rob A. I. de Vos, et al.. (2000). Cellular Expression of α7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease— A Stereological Approach. Neurobiology of Disease. 7(6). 666–672. 81 indexed citations
5.
Wevers, Andrea, Lothar Burghaus, Natasha Moser, et al.. (2000). Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approaches. Behavioural Brain Research. 113(1-2). 207–215. 67 indexed citations
6.
Wevers, Andrea, Lisa M. Monteggia, Sonja Nowacki, et al.. (1999). Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein. European Journal of Neuroscience. 11(7). 2551–2565. 131 indexed citations
7.
Schröder, Hannsjörg, E.N.H. Jansen, Andrea Wevers, et al.. (1995). Gene expression of the nicotinic acetylcholine receptor α4 subunit in the frontal cortex in Parkinson's disease patients. Neuroscience Letters. 187(3). 173–176. 17 indexed citations
8.
Wevers, Andrea, James P. Sullivan, Thomas P. Giordano, et al.. (1995). Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex. Drug Development Research. 36(2). 103–110. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026